Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07093528 · ClinicalTrials.gov registry record
A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
A clinical trial of Heart Failure With Preserved Ejection Fraction and Coronary Microvascular Dysfunction, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT07093528 is a study of Heart Failure With Preserved Ejection Fraction and Coronary Microvascular Dysfunction that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 25 participants, below the 2,288-participant average among 42 other Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07093528, a study of Heart Failure With Preserved Ejection Fraction and Coronary Microvascular Dysfunction, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Cardiovascular Magnetic Resonance (CMR)
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-10-16 |
| Est. Completion | 2027-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07093528
The ClinicalTrials.gov registry entry for NCT07093528 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,288-participant average among 42 other Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (99% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure With Preserved Ejection Fraction appearing as the primary indexed condition, and to 1 intervention - of which Cardiovascular Magnetic Resonance (CMR) is the first listed.
NCT07093528 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT07093528 about?
NCT07093528 is a clinical study titled "A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD". To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)
What is the current status of trial NCT07093528?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2025-10-16. Estimated completion is 2027-08.
What conditions does trial NCT07093528 study?
This clinical trial studies the following conditions: Heart Failure With Preserved Ejection Fraction, Coronary Microvascular Dysfunction.
What interventions are being tested in trial NCT07093528?
The interventions under investigation include: Cardiovascular Magnetic Resonance (CMR) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07093528?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07093528 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure With Preserved Ejection Fraction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)
RECRUITING · NA
-
Ketogenic Diet vs Mixed Diet in Patients With Heart Failure
RECRUITING · NA
-
Matching Perfusion and Metabolic Activity in HFpEF
RECRUITING · Phase 2
-
Pilot Study Lp299v Supplementation in Chronic Heart Failure
RECRUITING · NA
-
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
RECRUITING · Phase 3
-
Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction
RECRUITING · NA
Explore more on PlainTrial
Heart Failure With Preserved Ejection Fraction
All registered trials for this condition
Coronary Microvascular Dysfunction
All registered trials for this condition
Minnesota
All trials with a study site in Minnesota
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.